Pages that link to "Q35865232"
Jump to navigation
Jump to search
The following pages link to Therapeutic metformin/AMPK activation blocked lymphoma cell growth via inhibition of mTOR pathway and induction of autophagy (Q35865232):
Displaying 50 items.
- Repurposing metformin: an old drug with new tricks in its binding pockets (Q22250976) (← links)
- Protein kinase R-like ER kinase and its role in endoplasmic reticulum stress-decided cell fate (Q26801543) (← links)
- Autophagy modulation as a target for anticancer drug discovery (Q27025391) (← links)
- Metformin Reduces Desmoplasia in Pancreatic Cancer by Reprogramming Stellate Cells and Tumor-Associated Macrophages (Q27348974) (← links)
- Potential therapeutic approaches for modulating expression and accumulation of defective lamin A in laminopathies and age-related diseases (Q28391383) (← links)
- In Vitro Anti-Echinococcal and Metabolic Effects of Metformin Involve Activation of AMP-Activated Protein Kinase in Larval Stages of Echinococcus granulosus (Q28547202) (← links)
- Bcl-2high mantle cell lymphoma cells are sensitized to acadesine with ABT-199. (Q30395557) (← links)
- Comparison of Antidiabetic Medications during the Treatment of Atherosclerosis in T2DM Patients. (Q33678940) (← links)
- Metformin impairs growth of endometrial cancer cells via cell cycle arrest and concomitant autophagy and apoptosis (Q33804513) (← links)
- Metformin ameliorates hepatic steatosis and improves the induction of autophagy in HFD‑induced obese mice (Q33828153) (← links)
- Acute metformin preconditioning confers neuroprotection against focal cerebral ischaemia by pre-activation of AMPK-dependent autophagy (Q33842696) (← links)
- The pro-apoptotic role of autophagy in breast cancer (Q33918066) (← links)
- TOR-centric view on insulin resistance and diabetic complications: perspective for endocrinologists and gerontologists (Q34391710) (← links)
- Targeting autophagy overcomes Enzalutamide resistance in castration-resistant prostate cancer cells and improves therapeutic response in a xenograft model (Q34411761) (← links)
- The hepatitis C virus modulates insulin signaling pathway in vitro promoting insulin resistance (Q34469210) (← links)
- Autophagy plays a critical role in ChLym-1-induced cytotoxicity of non-hodgkin's lymphoma cells (Q34981512) (← links)
- GSTT1 deletion is related to polycyclic aromatic hydrocarbons-induced DNA damage and lymphoma progression (Q35107033) (← links)
- TAp73 promotes anabolism (Q35149652) (← links)
- Metformin inhibits growth of human glioblastoma cells and enhances therapeutic response (Q35600122) (← links)
- (Z)3,4,5,4'-trans-tetramethoxystilbene, a new analogue of resveratrol, inhibits gefitinb-resistant non-small cell lung cancer via selectively elevating intracellular calcium level. (Q36254754) (← links)
- Koschei the immortal and anti-aging drugs (Q36292001) (← links)
- Autophagy facilitates lung adenocarcinoma resistance to cisplatin treatment by activation of AMPK/mTOR signaling pathway (Q36390671) (← links)
- Metformin: Midlife maturity, maiden charm (Q36436404) (← links)
- Proteolytic systems and AMP-activated protein kinase are critical targets of acute myeloid leukemia therapeutic approaches. (Q36544596) (← links)
- Metformin selectively affects human glioblastoma tumor-initiating cell viability: A role for metformin-induced inhibition of Akt. (Q36604614) (← links)
- Metformin inhibits growth of human non-small cell lung cancer cells via liver kinase B-1-independent activation of adenosine monophosphate-activated protein kinase (Q36624074) (← links)
- Metformin inhibits growth and enhances radiation response of non-small cell lung cancer (NSCLC) through ATM and AMPK. (Q36896122) (← links)
- Autophagy in breast cancer and its implications for therapy (Q36966812) (← links)
- Activation of autophagy flux by metformin downregulates cellular FLICE-like inhibitory protein and enhances TRAIL- induced apoptosis (Q37269047) (← links)
- Cabazitaxel-induced autophagy via the PI3K/Akt/mTOR pathway contributes to A549 cell death (Q37297473) (← links)
- Metformin targets c-MYC oncogene to prevent prostate cancer. (Q37354564) (← links)
- Enhanced anti-tumor activity and cytotoxic effect on cancer stem cell population of metformin-butyrate compared with metformin HCl in breast cancer (Q37437550) (← links)
- Metformin protects against apoptosis and senescence in nucleus pulposus cells and ameliorates disc degeneration in vivo. (Q37465966) (← links)
- Metformin targets multiple signaling pathways in cancer (Q37609790) (← links)
- Metformin promotes autophagy and apoptosis in esophageal squamous cell carcinoma by downregulating Stat3 signaling (Q37620713) (← links)
- Rhein Inhibits Autophagy in Rat Renal Tubular Cells by Regulation of AMPK/mTOR Signaling (Q37676370) (← links)
- Rescue of mutant rhodopsin traffic by metformin-induced AMPK activation accelerates photoreceptor degeneration (Q37701985) (← links)
- Metformin promotes apoptosis in hepatocellular carcinoma through the CEBPD-induced autophagy pathway (Q37706711) (← links)
- Autophagy regulates inflammation following oxidative injury in diabetes (Q38076252) (← links)
- Senescence and aging: the critical roles of p53. (Q38082328) (← links)
- Repositioning metformin in cancer: genetics, drug targets, and new ways of delivery (Q38185970) (← links)
- Autophagy regulates insulin resistance following endoplasmic reticulum stress in diabetes (Q38336391) (← links)
- mTOR: a pharmacologic target for autophagy regulation (Q38345168) (← links)
- Metformin attenuates graft-versus-host disease via restricting mammalian target of rapamycin/signal transducer and activator of transcription 3 and promoting adenosine monophosphate-activated protein kinase-autophagy for the balance between T helper (Q38415035) (← links)
- Autophagy and protein kinase RNA-like endoplasmic reticulum kinase (PERK)/eukaryotic initiation factor 2 alpha kinase (eIF2α) pathway protect ovarian cancer cells from metformin-induced apoptosis (Q38428730) (← links)
- Clinical relevance of autophagic therapy in cancer: Investigating the current trends, challenges, and future prospects (Q38689955) (← links)
- Clinical outcome of treatment with serine-threonine kinase inhibitors in recurrent epithelial ovarian cancer: a systematic review of literature. (Q38813996) (← links)
- Metformin suppressed the proliferation of LoVo cells and induced a time-dependent metabolic and transcriptional alteration (Q38816034) (← links)
- A Metabolic Inhibitory Cocktail for Grave Cancers: Metformin, Pioglitazone and Lithium Combination in Treatment of Pancreatic Cancer and Glioblastoma Multiforme. (Q38885892) (← links)
- A triterpenoid saponin from Adenophora triphylla var. japonica suppresses the growth of human gastric cancer cells via regulation of apoptosis and autophagy (Q38963847) (← links)